Jon Cuthbert

Merck (NYSE:MRK) entered an exclusive global license agreement with SciBrunch Therapeutics for SPR2015, a preclinical oral KRAS G12D inhibitor being developed for potential cancer treatments.

Foresight Autonomous Holdings (NASDAQ:FRSX) signed a non-binding term sheet to acquire a 50.01% stake in a company advancing two data center projects in Poland.

Ramaco Resources (NASDAQ:METC) secured a $30 million court judgment for its subsidiary Ramaco Resources in an insurance coverage dispute against Chubb subsidiaries Federal Insurance Company and ACE American Insurance Company.

South Korea’s Financial Services Commission has begun considering market-making rules for digital assets.

Brixmor Property Group (NYSE:BRX) and Everview Partners agreed to acquire Slate Grocery REIT in a $2.34 billion transaction involving 115 grocery-anchored centers.

MediciNova (NASDAQ:MNOV) reported topline results from a Phase 2 placebo-controlled trial evaluating MN-001, also known as tipelukast, in patients with type 2 diabetes, fatty liver disease, and elevated triglycerides.

NVIDIA (NASDAQ:NVDA) introduced its Open Agent Safety Platform, an open-source framework designed to provide controls for AI agents through runtime monitoring and policy enforcement tools.

QIAGEN (NYSE:QGEN) received U.S. Food and Drug Administration clearance for its QIAstat-Dx BCID GN Plus AMR Panel, expanding access to its bloodstream infection testing portfolio for U.S. laboratories.

Cleanaway Waste Management (ASX:CWY) has received written reconfirmation from EQT Infrastructure regarding its $9.4 billion takeover proposal.

Ingenia Communities Group (ASX:INA) received a revised $5.25 per security cash buyout proposal from Warburg Pincus.